Inovio to present at upcoming scientific conference

Plymouth meeting, pa. , sept. 17, 2024 /prnewswire/ -- inovio (nasdaq:ino), a biotechnology company focused on developing and commercializing dna medicines to help treat and protect people from hpv-related diseases, cancer, and infectious diseases, today announced that it will present at the following scientific conference: world congress of electroporation oral presentation by trevor smith, vp of preclinical r&d at inovioabstract title: development of in vivo-launched synthetic dna-encoded antibodies employing cellectra® electroporation technology date and time: september 18, 2024, 3:20pm – 3:35pm cet location: rome, italy the abstract from the conference will be made available on inovio's website following the data presentation.
INO Ratings Summary
INO Quant Ranking